Abstract
Selection of treatment for non-melanoma skin cancer (NMSC) takes into account many factors, including different host, tumor and treatment factors. Examples of these factors are presented. Ultimately the treatment decision is affected by the availability of surgical, dermatological, radiotherapeutic expertise and supportive resources. Different treatment options are discussed in this review. After appropriate education and guidance, patients' wish should take the first priority. The treatment of skin cancer requires experience, and discussion in multidisciplinary team meetings is strongly encouraged.
Keywords: Chemotherapy, cryosurgery, electrodessication and curettage, plastic surgery, radiotherapy, skin, surgery.
Graphical Abstract
Current Cancer Therapy Reviews
Title:Treatment Decisions for Non-Melanoma Skin Cancer (NMSC)
Volume: 12 Issue: 2
Author(s): Khanh Vu, Patricia Tai, Arbind Dubey, Rashmi Koul and Elizabeth A. Barnes
Affiliation:
Keywords: Chemotherapy, cryosurgery, electrodessication and curettage, plastic surgery, radiotherapy, skin, surgery.
Abstract: Selection of treatment for non-melanoma skin cancer (NMSC) takes into account many factors, including different host, tumor and treatment factors. Examples of these factors are presented. Ultimately the treatment decision is affected by the availability of surgical, dermatological, radiotherapeutic expertise and supportive resources. Different treatment options are discussed in this review. After appropriate education and guidance, patients' wish should take the first priority. The treatment of skin cancer requires experience, and discussion in multidisciplinary team meetings is strongly encouraged.
Export Options
About this article
Cite this article as:
Vu Khanh, Tai Patricia, Dubey Arbind, Koul Rashmi and Barnes A. Elizabeth, Treatment Decisions for Non-Melanoma Skin Cancer (NMSC), Current Cancer Therapy Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/1573394712666160921151835
DOI https://dx.doi.org/10.2174/1573394712666160921151835 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metal Oxide Nanomaterials in Nanomedicine: Applications in Photodynamic Therapy and Potential Toxicity
Current Topics in Medicinal Chemistry Induced pluripotent stem cell-derived mesenchymal stem cells: A leap toward personalized therapies.
Current Stem Cell Research & Therapy Dysregulation of Lysyl Oxidases Expression in Diabetic Nephropathy and Renal Cell Carcinoma
Current Drug Targets Snake Venom Phospholipases A2: A New Class of Antitumor Agents
Protein & Peptide Letters Genetically Engineered Stem Cells for Therapeutic Gene Delivery
Current Gene Therapy Genetic Surgery - A Right Strategy to Attack Cancer
Current Gene Therapy Cadmium-containing Quantum Dots: Current Perspectives on Their Application as Nanomedicine and Toxicity Concerns
Mini-Reviews in Medicinal Chemistry Effects of LPA and S1P on the Nervous System and Implications for Their Involvement in Disease
Current Drug Targets The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Advances in α(v)β(3) Integrin-Targeting Cancer Therapy and Imaging with Radiolabeled RGD Peptides
Current Radiopharmaceuticals Toxicity of Biodegradable Nanoscale Preparations
Current Drug Metabolism Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
Current Stem Cell Research & Therapy Transient Receptor Potential Channels and Dermatological Disorders
Current Topics in Medicinal Chemistry Alternative Splicing, DNA Damage and Modulating Drugs in Radiation Therapy for Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Chromogranin A and the Endothelial Barrier Function
Current Medicinal Chemistry Patents on Therapeutic and Cosmetic Applications of Bioactives of Crocus Sativus L. and their Production through Synthetic Biology Methods: A Review
Recent Patents on Biotechnology Passive and Active Tumour Targeting with Nanocarriers
Current Drug Discovery Technologies Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients
Current Pharmaceutical Design Radiotherapy for Non-Melanoma Skin Cancer
Current Cancer Therapy Reviews